• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

Introduction to (1,3-oxazol-2-yl)methanamine (CAS No. 885331-17-9)

(1,3-oxazol-2-yl)methanamine, with the CAS number 885331-17-9, is a significant compound in the field of chemical and pharmaceutical research. This heterocyclic amine derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The oxazole ring, a key feature of this compound, contributes to its stability and reactivity, making it a valuable scaffold for drug development.

The compound's structure consists of an oxazole ring linked to a methanamine group. This configuration allows for diverse chemical modifications, enabling researchers to tailor its properties for specific applications. The oxazole ring is known for its ability to participate in hydrogen bonding and metal coordination, which are crucial for the design of bioactive molecules.

In recent years, there has been growing interest in oxazole derivatives due to their broad spectrum of biological activities. Studies have shown that these compounds exhibit antimicrobial, anti-inflammatory, and anticancer properties. The presence of the amine group in (1,3-oxazol-2-yl)methanamine enhances its potential as a pharmacophore, facilitating interactions with biological targets.

One of the most compelling aspects of (1,3-oxazol-2-yl)methanamine is its role in the development of novel therapeutic agents. Researchers have been exploring its use in synthesizing small-molecule inhibitors targeting various disease pathways. For instance, studies have demonstrated its efficacy in inhibiting enzymes involved in cancer progression. The compound's ability to modulate these enzymatic activities makes it a promising candidate for further investigation.

The synthesis of (1,3-oxazol-2-yl)methanamine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to improve yield and purity. Techniques such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions have been particularly useful in constructing the desired framework.

From a computational chemistry perspective, the molecular modeling of (1,3-oxazol-2-yl)methanamine has provided valuable insights into its interactions with biological targets. These studies have helped in understanding the binding modes and affinity of the compound towards specific receptors. This information is crucial for designing more effective drugs with improved pharmacokinetic profiles.

The pharmaceutical industry has shown considerable interest in developing derivatives of (1,3-oxazol-2-yl)methanamine for clinical applications. Preclinical studies have highlighted its potential in treating various conditions, including neurodegenerative diseases and autoimmune disorders. The compound's ability to cross the blood-brain barrier and exert targeted effects makes it an attractive option for drug development.

Environmental considerations also play a role in the research and application of (1,3-oxazol-2-yl)methanamine. Efforts are being made to develop sustainable synthetic routes that minimize waste and reduce environmental impact. Green chemistry principles are being integrated into the synthesis process to ensure that the production of this compound is both efficient and eco-friendly.

The future prospects of (1,3-oxazol-2-yl)methanamine are promising, with ongoing research aimed at uncovering new applications and improving existing ones. Collaborative efforts between academia and industry are essential to translate laboratory findings into viable therapeutic solutions. As our understanding of this compound grows, so does its potential to contribute to advancements in medicine and chemistry.

• 1083396-36-4(1-(Oxazol-2-yl)ethanamine)
• 1017228-56-6((5-Methyl-1,3-oxazol-2-yl)methanamine)
• 1041053-44-4(1,3-oxazol-2-ylmethanamine hydrochloride)
• 1196151-82-2(N-methyl-1-(4-methyl-1,3-oxazol-2-yl)methanamine)
• 884539-45-1(1,3-oxazole-2-carboxamide)
• 907544-38-1(Oxazol-2-ylmethanamine hydrochloride)
• 1108725-99-0((4-methyl-1,3-oxazol-2-yl)methanamine)
• 23012-10-4(2-methyl-1,3-oxazole)
• 1955561-52-0(1-(1,3-oxazol-2-yl)methylpiperazine dihydrochloride)
• 1391733-72-4((4-Methyloxazol-2-yl)methanamine hydrochloride)